- ... GRADE evidence profile: What are the most effective adjuvant intravesical therapy (chemotherapy or immunotherapy) ... Table 33 GRADE evidence profile: What ...
- ... or 4 worst overall toxicities H.14.10. Adjuvant immunotherapy versus no adjuvant therapy in resected pancreatic cancer patients Figure 406 ...
- ... n=61) showed no clinically important difference between adjuvant immunotherapy (MoAb 494/32) and no adjuvant therapy on ... n=61) showed no clinically important difference between adjuvant immunotherapy (MoAb 494/32) and no adjuvant therapy on ...
- ... relevant to PICO. Davar D, Tarhini, et al. Adjuvant immunotherapy of melanoma and development of new approaches using ...
- ... for the StatRoc study (A Feasibility Study of Adjuvant Statin Therapy in the Prevention of Post-Operative Recurrence of Oesophageal Adenocarcinoma). Funded by NIHR. No ...
- ... Goodwin A, Parker S, Ghersi D, et al.: Post-operative radiotherapy for ductal carcinoma ... National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Unanswered questions ...
- ... or double intravesical epirubicin instillation in the early postoperative period to prevent ... A, et al. Adjuvant chemotherapy with early intravesical instillation of adriamycin and ...
- NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ...Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, D.C. : For sale by the Supt. of Docs., U.S. G.P.O., 1994... In antigen-antibody complex QW 570 Immunostimulants see Adjuvants, Immunologic ... Immunologic Immunotherapy QW 940-949 Of a particular disease, with ...
- NLM Digital Collections - Beikoku Kokuritsu Igaku Toshokan bunruihō : igaku oyobi kanren bun'ya ni okeru tosho haikahōPublication: Tōkyō : Nihon Igaku Toshokan Kyōkai, 1996... In antigen-antibody complex QW 570 Immunostimulants see Adjuvants, Immunologic ... Immunologic Immunotherapy QW 940-949 Of a particular disease, with ...
- ... Adoptive Transfer E05.478.550.520.050.400 Immunotherapy, Adoptive E05.478.550.545 Immunization Schedule E05. ... 550.550 Immunization, Secondary E05.478.550.600 Immunotherapy, Active E05.478.550.600.890 Vaccination E05. ...
32 results